Acadia Pharmaceuticals (ACAD) Inventory (2016 - 2026)

Acadia Pharmaceuticals' Inventory history runs 11 years deep, the most recent figure standing at $31.6 million for Q1 2026.

• In Q1 2026, Inventory rose 37.59% year-over-year to $31.6 million; the TTM figure through Mar 2026 stood at $31.6 million (up 37.59% YoY), while the FY2025 annual figure was $34.7 million, up 57.96% from the prior year.
• Inventory was $31.6 million for Q1 2026 at Acadia Pharmaceuticals, down from $34.7 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $71.5 million in Q2 2024 to a low of $5.8 million in Q3 2022.
• Historically, Inventory has averaged $27.0 million across 5 years, with a median of $22.9 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Inventory soared 916.18% in 2024, then tumbled 63.48% in 2025.
• A 5-year view of Inventory shows it stood at $6.6 million in 2022, then jumped by 439.77% to $35.8 million in 2023, then tumbled by 38.72% to $21.9 million in 2024, then soared by 57.96% to $34.7 million in 2025, then slipped by 8.93% to $31.6 million in 2026.
• The last three Inventory figures came in at $31.6 million (Q1 2026), $34.7 million (Q4 2025), and $29.1 million (Q3 2025), per Business Quant data.